|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 260.40 DKK | +1.24% |
|
+9.37% | -19.94% |
| 18/04 | Health Care Up Ahead of Earnings - Health Care Roundup | DJ |
| 18/04 | Kailera makes a splash on Nasdaq as anti-obesity drug frenzy continues |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 309.22 | +20.23% | 22 | ||||||
| 1,209.86 | +33.84% | 29 | ||||||
| 251.08 | +7.05% | 24 | ||||||
| 249 | +19.14% | 29 | ||||||
| 220.22 | +9.53% | 21 | ||||||
| 129.81 | +12.43% | 27 | ||||||
| 153.93 | +2.78% | 21 | ||||||
| 352.03 | +0.76% | 29 | ||||||
| 158.18 | +14.17% | 28 | ||||||
| 28.97 | +6.41% | 27 | ||||||
| 63.04 | +6.92% | 25 | ||||||
| 96.18 | +18.96% | 23 | ||||||
| 20.48 | -3.51% | 20 | ||||||
| 548.45 | +25.89% | 29 | ||||||
| 9,923.33 | +15.51% | 15 | ||||||
| 6,036.87 | +6.92% | 15 | ||||||
| 80.33 | +39.78% | 17 | ||||||
| 47.58 | +16.93% | 19 | ||||||
| Average | 1,104.36 | +14.10% | 23 | ||||||
| Weighted average by Cap. | 700.77 | +15.69% | 25 |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition